Media headlines about Varian Medical Systems (NYSE:VAR) have been trending somewhat positive recently, Accern reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Varian Medical Systems earned a media sentiment score of 0.11 on Accern’s scale. Accern also assigned news coverage about the medical equipment provider an impact score of 46.1713474957462 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Here are some of the media stories that may have effected Accern Sentiment Analysis’s analysis:
- Varian Medical Systems, Inc. (NYSE:VAR) – An Eye on Stock Value – Nasdaq Journal (press release) (nasdaqjournal.com)
- Varian to Open Facility in Brazil, Global Growth in Focus – Nasdaq (nasdaq.com)
- Varian Medical Systems, Inc. (NYSE: VAR) – Volume: A Tool to Project Future Performance – Alpha Beta Stock (alphabetastock.com)
- Varian Medical : Announces Opening of New Facility in Brazil (4-traders.com)
Shares of Varian Medical Systems (VAR) traded up $0.39 during midday trading on Wednesday, hitting $108.79. The stock had a trading volume of 589,002 shares, compared to its average volume of 870,540. Varian Medical Systems has a twelve month low of $76.94 and a twelve month high of $110.23. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.41 and a quick ratio of 1.13. The firm has a market capitalization of $10,028.33, a PE ratio of 28.98, a PEG ratio of 3.21 and a beta of 0.65.
Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.19 by ($0.10). Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The firm had revenue of $739.00 million during the quarter, compared to analyst estimates of $741.69 million. During the same period in the previous year, the firm posted $1.03 earnings per share. The company’s quarterly revenue was down 1.1% compared to the same quarter last year. analysts expect that Varian Medical Systems will post 4.26 EPS for the current year.
A number of equities analysts recently commented on VAR shares. Royal Bank Of Canada reiterated a “hold” rating and set a $100.00 price objective on shares of Varian Medical Systems in a research report on Friday, September 1st. BTIG Research downgraded Varian Medical Systems from a “buy” rating to a “neutral” rating in a research report on Thursday, September 7th. They noted that the move was a valuation call. Robert W. Baird reiterated a “hold” rating and set a $99.00 price objective on shares of Varian Medical Systems in a research report on Monday, August 28th. Zacks Investment Research downgraded Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, October 27th. Finally, Citigroup Inc. lifted their price objective on Varian Medical Systems from $119.00 to $121.00 and gave the stock a “neutral” rating in a research report on Monday, October 30th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $97.83.
In related news, insider Dow R. Wilson sold 15,059 shares of the business’s stock in a transaction on Thursday, September 7th. The stock was sold at an average price of $105.41, for a total transaction of $1,587,369.19. Following the completion of the transaction, the insider now directly owns 81,835 shares of the company’s stock, valued at approximately $8,626,227.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Kolleen T. Kennedy sold 931 shares of the business’s stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $105.00, for a total value of $97,755.00. Following the transaction, the executive vice president now directly owns 27,531 shares of the company’s stock, valued at $2,890,755. The disclosure for this sale can be found here. Insiders sold 42,761 shares of company stock valued at $4,447,864 over the last ninety days. Insiders own 0.91% of the company’s stock.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.